Pharmaceutical Classification: Altretamine (Hexamethylmelamine)
In the pharmaceutical industry, Altretamine is a unique and technically complex molecule. While it is often grouped with common chemotherapy drugs, its specific chemical behavior and metabolic activation place it in a specialized niche. As a pharmacist and manufacturer, I view Altretamine as a “Miscellaneous Alkylating-like Agent”—it is technically designed to act as a prodrug that requires hepatic activation to damage cancer cell DNA.
At your WHO-GMP facility in Mumbai, Altretamine is classified under Antineoplastic Agents for regulatory and export purposes, specifically for the treatment of refractory ovarian cancer.
1. Therapeutic Classification
Main Class: Antineoplastic (Anti-cancer) Agent.
Sub-Class: Cytotoxic Chemotherapy.
Clinical Category: Salvage Therapy / Second-line Agent.
ATC Code: L01XX03 (L = Antineoplastic and immunomodulating agents; L01 = Antineoplastic agents; L01X = Other antineoplastic agents).
2. Chemical Classification
Chemical Family: s-Triazine Derivative (specifically an Ethylentimine/Methylmelamine derivative).
Chemical Name: $N,N,N’,N’,N”,N”$-hexamethyl-1,3,5-triazine-2,4,6-triamine.
Structure: It consists of a triazine ring with six methyl groups attached to the three nitrogen atoms of the amino groups.
3. Pharmacological Classification (Mechanism of Action)
Technically, Altretamine is classified as an Alkylating Agent, but it does not fit the classical pattern of Nitrogen Mustards or Nitrosoureas.
Mechanism Category: DNA Cross-linking Agent.
Metabolic Classification: Prodrug.
It remains inactive until it reaches the liver.
It is activated by Cytochrome P450 (CYP1A) enzymes via N-demethylation.
Active Intermediates: It forms reactive Methylol species (e.g., pentamethylmelamine) and Formaldehyde.
Action: These reactive intermediates form covalent bonds with DNA, causing inter-strand and intra-strand cross-links that prevent DNA replication and lead to cell death.
4. Regulatory & Handling Classification
From a manufacturing and B2B standpoint at your facility in Mumbai, Altretamine falls under strict safety classifications:
Hazard Class: Cytotoxic / Hazardous Drug.
Requires specialized containment (Isolators/Negative Pressure) during the formulation of 50 mg capsules.
Pregnancy Category: Category D (Evidence of human fetal risk).
USP/NF Status: Compendial standards for purity and dissolution are strictly followed to ensure B2B quality.
The Manufacturer’s Perspective: Technical & Export
The “Unique Class” USP: On your digital marketplace, highlight that Altretamine is a “Non-Cross-Resistant Alkylator.” This technical classification is its biggest selling point for B2B oncology buyers—it works even when traditional platinum-based alkylating agents have failed.
Market Positioning: Market it as a “Synthetic s-Triazine Derivative.” This high-level technical classification positions your firm as a specialized manufacturer of complex, niche molecules.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers classifying Altretamine under “Other Antineoplastic Agents” to support your registration in international B2B oncology tenders.